{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T17:39:04Z","timestamp":1779385144518,"version":"3.53.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T00:00:00Z","timestamp":1739059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejpb.2025.114650","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T11:03:45Z","timestamp":1737803025000},"page":"114650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hexahistidine-metal assembly encapsulated fibroblast growth factor 21 for lipopolysaccharide-induced acute lung injury"],"prefix":"10.1016","volume":"208","author":[{"given":"Lanlan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanghang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofeng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqiong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10358","key":"10.1016\/j.ejpb.2025.114650_b0005","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","article-title":"Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management","volume":"400","author":"Gorman","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114650_b0010","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome advances in diagnosis and treatment","volume":"319","author":"Fan","year":"2018","journal-title":"Jama-J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/cc11144","article-title":"Clinical review: early treatment of acute lung injury\u2013paradigm shift toward prevention and treatment prior to respiratory failure","volume":"16","author":"Levitt","year":"2012","journal-title":"Crit. Care"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114650_b0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/ers.10.71","article-title":"The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine","volume":"4","author":"Chen","year":"2010","journal-title":"Expert. Rev. Respir. Med."},{"key":"10.1016\/j.ejpb.2025.114650_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fphys.2020.00036","article-title":"Molecular dynamics of lipopolysaccharide-induced lung injury in rodents","volume":"11","author":"Domscheit","year":"2020","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114650_b0030","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/jcmm.13421","article-title":"Site-specific and endothelial-mediated dysfunction of the alveolar-capillary barrier in response to lipopolysaccharides","volume":"22","author":"Janga","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00418-018-1737-y","article-title":"Air-blood barrier thickening and alterations of alveolar epithelial type 2 cells in mouse lungs with disrupted hepcidin\/ferroportin regulatory system","volume":"151","author":"Muhlfeld","year":"2019","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.ejpb.2025.114650_b0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fbioe.2020.00105","article-title":"Lung microvascular niche, repair, and engineering","volume":"8","author":"Tsuchiya","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2025.114650_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107419","article-title":"The receptor for advanced glycation end products mediates dysfunction of airway epithelial barrier in a lipopolysaccharides-induced murine acute lung injury model","volume":"93","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114650_b0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.addr.2005.01.009","article-title":"Occludin: structure, function and regulation","volume":"57","author":"Feldman","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114650_b0055","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cell.2006.06.043","article-title":"ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation","volume":"126","author":"Umeda","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejpb.2025.114650_b0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/gt.2016.19","article-title":"beta1-Na(+),K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury","volume":"23","author":"Lin","year":"2016","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.chest.2018.10.022","article-title":"Lung repair and regeneration in ARDS: role of PECAM1 and wnt signaling","volume":"155","author":"Villar","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.ejpb.2025.114650_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111026","article-title":"Alveolar epithelial glycocalyx shedding aggravates the epithelial barrier and disrupts epithelial tight junctions in acute respiratory distress syndrome","volume":"133","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s10020-022-00502-8","article-title":"FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stress","volume":"28","author":"Dhlamini","year":"2022","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2025.114650_b0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.5290","article-title":"Effect of FGF\/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts","volume":"249","author":"Hegab","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.ejpb.2025.114650_b0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cytogfr.2021.09.002","article-title":"FGF\/FGFR signaling: from lung development to respiratory diseases","volume":"62","author":"Yang","year":"2021","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.ejpb.2025.114650_b0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s42255-021-00354-2","article-title":"Metabolic Messengers: FGF21","volume":"3","author":"Flippo","year":"2021","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.ejpb.2025.114650_b0100","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","article-title":"The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic","volume":"16","author":"Geng","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10753-023-01905-3","article-title":"Fibroblast growth factor 21 relieves lipopolysaccharide-induced acute lung injury by suppressing JAK2\/STAT3 signaling pathway","volume":"47","author":"Cai","year":"2024","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114650_b0110","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2013association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114650_b0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/BJ20151085","article-title":"Circulating FGF21 proteolytic processing mediated by fibroblast activation protein","volume":"473","author":"Zhen","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejpb.2025.114650_b0120","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jconrel.2020.05.036","article-title":"Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects","volume":"324","author":"Watanabe","year":"2020","journal-title":"J. Control Rel."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114650_b0125","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1389200219666180305154119","article-title":"Pharmacokinetics, metabolism, distribution and permeability of nanomedicine","volume":"19","author":"Ravindran","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejpb.2025.114650_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review","volume":"15","author":"Hossen","year":"2019","journal-title":"J. Adv. Res."},{"issue":"10","key":"10.1016\/j.ejpb.2025.114650_b0135","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.apsb.2021.04.023","article-title":"Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design","volume":"11","author":"Qiao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2025.114650_b0140","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.2147\/IJN.S300594","article-title":"Nanomedicine-based therapeutics to combat acute lung injury","volume":"16","author":"Bian","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejpb.2025.114650_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123321","article-title":"Precise nanodrug delivery systems with cell-specific targeting for ALI\/ARDS treatment","volume":"644","author":"Lin","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2025.114650_b0150","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.2147\/IJN.S332279","article-title":"Efficient delivery of antibodies intracellularly by Co-assembly with hexahistidine-metal assemblies (HmA)","volume":"16","author":"Wei","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.ejpb.2025.114650_b0155","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1021\/acs.molpharmaceut.0c00212","article-title":"Hexahistidine-metal assemblies: a facile and effective codelivery system of subunit vaccines for potent humoral and cellular immune responses","volume":"17","author":"Zhang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2025.114650_b0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.actbio.2021.05.001","article-title":"Efficient delivery of cytosolic proteins by protein-hexahistidine-metal co-assemblies","volume":"129","author":"Huang","year":"2021","journal-title":"Acta Biomater."},{"issue":"23","key":"10.1016\/j.ejpb.2025.114650_b0165","article-title":"pH-responsive hexa-histidine metal assembly (HmA) with enhanced biocatalytic cascades as the vehicle for glucose-mediated long-acting insulin delivery","volume":"10","author":"Zhou","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"issue":"10358","key":"10.1016\/j.ejpb.2025.114650_b0170","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","article-title":"Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes","volume":"400","author":"Bos","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0175","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.1038\/s41467-024-51683-1","article-title":"Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation","volume":"15","author":"Chung","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10753-022-01726-w","article-title":"The role of macrophages and alveolar epithelial cells in the development of ARDS","volume":"46","author":"Tao","year":"2023","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.ejpb.2025.114650_b0185","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.chest.2019.06.012","article-title":"The emerging role of neutrophil extracellular traps in respiratory disease","volume":"156","author":"Twaddell","year":"2019","journal-title":"Chest"},{"issue":"3\u20134","key":"10.1016\/j.ejpb.2025.114650_b0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/molmed.2010.00138","article-title":"Contribution of neutrophils to acute lung injury","volume":"17","author":"Grommes","year":"2011","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1165\/rcmb.2013-0148OC","article-title":"Neutrophil-endothelial interactions mediate angiopoietin-2-associated pulmonary endothelial cell dysfunction in indirect acute lung injury in mice","volume":"50","author":"Lomas-Neira","year":"2014","journal-title":"Am. J. Respir Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.ejpb.2025.114650_b0200","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/thoraxjnl-2015-207461","article-title":"The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities","volume":"71","author":"Millar","year":"2016","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114650_b0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nri3600","article-title":"Alveolar macrophages: plasticity in a tissue-specific context","volume":"14","author":"Hussell","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114650_b0210","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.7150\/thno.69533","article-title":"AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages","volume":"12","author":"Xia","year":"2022","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114650_b0215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114650_b0220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejpb.2025.114650_b0225","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/resp.12969","article-title":"Efficacy of early sivelestat administration on acute lung injury and acute respiratory distress syndrome","volume":"22","author":"Kido","year":"2017","journal-title":"Respirology"},{"issue":"23","key":"10.1016\/j.ejpb.2025.114650_b0230","doi-asserted-by":"crossref","first-page":"23872","DOI":"10.1021\/acsnano.3c08147","article-title":"Molybdenum nanodots for acute lung injury therapy","volume":"17","author":"Yan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2025.114650_b0235","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jconrel.2024.09.013","article-title":"Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier","volume":"375","author":"Sun","year":"2024","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2025.114650_b0240","first-page":"406","article-title":"Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization","volume":"43","author":"Liao","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejpb.2025.114650_b0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jconrel.2016.05.039","article-title":"Delivery of the high-mobility group box 1 box A peptide using heparin in the acute lung injury animal models","volume":"234","author":"Song","year":"2016","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2025.114650_b0250","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jconrel.2022.08.021","article-title":"Advanced formulations and nanotechnology-based approaches for pulmonary delivery of sildenafil: a scoping review","volume":"350","author":"Lazo","year":"2022","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2025.114650_b0255","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2015.06.038","article-title":"Passive targeting of phosphatiosomes increases rolipram delivery to the lungs for treatment of acute lung injury: an animal study","volume":"213","author":"Fang","year":"2015","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2025.114650_b0260","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.02.030","article-title":"Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis","volume":"321","author":"Yang","year":"2020","journal-title":"J. Control Rel."},{"issue":"18","key":"10.1016\/j.ejpb.2025.114650_b0265","doi-asserted-by":"crossref","first-page":"16380","DOI":"10.1021\/acsami.9b04051","article-title":"pH-responsive nanoparticles targeted to lungs for improved therapy of acute lung inflammation\/injury","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interf."},{"issue":"1","key":"10.1016\/j.ejpb.2025.114650_b0270","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1080\/10717544.2017.1402217","article-title":"Surfactant protein-a nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/nano11030749","article-title":"PLGA based nanospheres as a potent macrophage-specific drug delivery system","volume":"11","author":"Boltnarova","year":"2021","journal-title":"Nanomaterials (Basel)"},{"issue":"15","key":"10.1016\/j.ejpb.2025.114650_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/nano13152225","article-title":"Recent studies and progress in the intratumoral administration of nano-sized drug delivery systems","volume":"13","author":"Yun","year":"2023","journal-title":"Nanomaterials (Basel)"},{"issue":"2","key":"10.1016\/j.ejpb.2025.114650_b0285","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.ejpb.2025.114650_b0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049345","article-title":"Rationale-based engineering of a potent long-acting FGF21 analog for the treatment of type 2 diabetes","volume":"7","author":"Hecht","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2025.114650_b0295","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijbiomac.2019.05.167","article-title":"An efficient large-scale refolding technique for recovering biologically active recombinant human FGF-21 from inclusion bodies","volume":"135","author":"Ye","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ejpb.2025.114650_b0300","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00441-016-2534-3","article-title":"Looking ahead: where to next for animal models of bronchopulmonary dysplasia?","volume":"367","author":"Nardiello","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejpb.2025.114650_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"issue":"5","key":"10.1016\/j.ejpb.2025.114650_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052903","article-title":"Animals in respiratory research","volume":"25","author":"Frohlich","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:40:34Z","timestamp":1762332034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":62,"alternative-id":["S0939641125000268"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114650","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hexahistidine-metal assembly encapsulated fibroblast growth factor 21 for lipopolysaccharide-induced acute lung injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114650","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114650"}}